Beyzavi Group

About Us

 

 

The research in Beyzavi Group at the University of Arkansas involves the synthesis and study of new transition metal-based catalysts and materials for applications in cancer therapy, e.g. photodynamic therapy (PDT) and chemotherapy; biomedical imaging, e.g. positron emission tomography (PET); energy sustainability, and small molecule activation. Our goal is the creative use of nature-inspired cooperative interactions to achieve new modes of reactivity.

 

Our Research Highlights

Anticancer Nano Drug Candidates: KNWA/FOX24 TV, NewsWire, Research Frontiers, ScienceDaily, KLRT Fox 16, KARK-TV, Ed 88, Center for Health Education, Awareness Resources and Services (CHEARS)Business Standard, News Break, Pharmacy Times, StudyFinds, Times of RepublicBreast Cancers, Bright Surf, Social News

Pt- and Au-based Anticancer Drugs: KNWA TV, FOX24 TV, NewsWire, Fulbright REVIEWThe Arkansas Traveler Newspaper

Funding: NewsWire (NIH Funding on PET Imaging), Arkansas Democrat Gazette (NIH Funding on PET Imaging), UA Notebook (NIH Funding for PET Imaging), NewsWire (DoD Funding on Water Purification)

 

Click on each image to read more on our recent federally funded projects: